For the active substances amisulbrom and S-abscisic acid, as the Authority needs additional time to reach a conclusion on their risk assessment , the duration of the extension of the approval period for these active substances should be set at 23 months and 2 weeks.
Recital 9, Regulation (EU) 2024/1892
In forcesince 10 Jul 2024